Ocuphire Pharma, Inc. (OCUP) Earnings
|
Expand Research on OCUP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -33.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/8/24 | Q324 | N/A | -$0.26 | N/A | N/A | $2.1M | N/A | N/A | N/A | ||
8/13/24  |
Q224 | -$0.30 | -$0.24 | -$0.06 | $1.11M | $2.6M | N/A |  | | Details | |
| 8/9/24 | Q224 | N/A | -$0.24 | N/A | N/A | $2.6M | N/A | N/A | N/A | ||
| 5/3/24 | Q124 | N/A | -$0.11 | N/A | N/A | $5.34M | N/A | N/A | N/A | ||
| 3/8/24 | Q423 | -$0.21 | -$0.05 | -$0.16 | $1.69M | $5.36M | N/A | | | Details | |
| 11/13/23 | Q323 | $0.25 | -$0.22 | +$0.47 | $11.9M | $3.03M | N/A | | | Details | |
| 11/10/23 | Q323 | N/A | -$0.22 | N/A | N/A | $3.03M | N/A | N/A | N/A | ||
| 8/11/23 | Q223 | -$0.24 | -$0.23 | -$0.01 | $3.67M | $2.43M | N/A | | | Details |
